They demonstrated that CLDN6 attenuates hypoxia-induced tumor metastasis via SUMOylation and they speculated that these findings might provide a novel strategy to treat BC and a mechanism to be exploited in anti-cancer therapy (Jia et al., 2020). Here, CLDN6 is linked to neoplasm.